Lv3
270 积分 2024-09-12 加入
Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator
4天前
已完结
Matrix-producing neutrophils populate and shield the skin
4天前
已完结
The danger theory of immunity revisited
24天前
已完结
Exposure to autoimmune disorders is associated with increased Alzheimer’s disease risk in a multi-site electronic health record analysis
1个月前
已完结
Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following damage
1个月前
已完结
A systematic review of interleukin-31 inhibitors in the treatment of prurigo nodularis
1个月前
已完结
Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases
1个月前
已完结
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
2个月前
已完结
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
2个月前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, placebo-controlled phase 3 trial
2个月前
已完结
皖公网安备34019202002308
